MiR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin;
Patel, N, Garikapati, KR, Pandita, RK, Singh, DK, Pandita, TK, Bhadra, U & Bhadra, MP 2017, Scientific Reports, vol 7, no. 1, 4263. DOI:

Transcription regulation of CDKN1A (p21/CIP1/WAF1) by TRF2 is epigenetically controlled through the REST repressor complex;
Hussain, T, Saha, D, Purohit, G, Kar, A, Kishore Mukherjee, A, Sharma, S, Sengupta, S, Dhapola, P, Maji, B, Vedagopuram, S, Horikoshi, NT, Horikoshi, N, Pandita, RK, Bhattacharya, S, Bajaj, A, Riou, JF, Pandita, TK & Chowdhury, S 2017, Scientific Reports, vol 7, no. 1, 11541. DOI:

Addition of chemotherapy to hypofractionated radiotherapy for glioblastoma: practice patterns, outcomes, and predictors of survival;
Haque, W, Verma, V, Butler, EB & Teh, BS 2017, Journal of Neuro-Oncology, pp. 1-9. DOI:

Radiation therapy utilization and outcomes for older women with breast cancer: Impact of molecular subtype and tumor grade;
Haque, W, Kee Yuan, DM, Verma, V, Butler, EB, Teh, BS, Wiederhold, L & Hatch, S 2017, Breast, vol 35, pp. 34-41. DOI:

Radical cystectomy versus chemoradiation for muscle-invasive bladder cancer: Impact of treatment facility and sociodemographics;
Haque, W, Verma, V, Butler, EB & Teh, BS 2017, Anticancer Research, vol 37, no. 10, pp. 5603-5608. DOI:

Radiotherapy for renal cell carcinoma: Renaissance of an overlooked approach;
Siva, S, Kothari, G, Muacevic, A, Louie, AV, Slotman, BJ, Teh, BS & Lo, SS 2017, Nature Reviews Urology, vol 14, no. 9, pp. 549-563. DOI:

Stereotactic body radiation therapy for prostate cancer-a review;
Haque, W, Butler, EB & Teh, BS 2017, Chinese Clinical Oncology, vol 6, S10. DOI: